Reed Smith to host 12th Annual Virtual Health Care Week March 16 through March 19

For anyone working in the health and life sciences industries and looking to complete CLE hours, or who just wants to keep up to date on the quickly changing world of Health Care and Life Sciences law, Reed Smith will be hosting its 12th annual Virtual Health Care Week March 16 through March 19.

This four-day event will explore recent developments, challenges, and opportunities facing U.S. and multinational health care providers, life sciences companies, and industry investors. 

The presentations will also be available for viewing on demand for registered attendees. However, CLE credit for on-demand viewing will only be available for those licensed in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia.

Anyone who wishes to attend can register now for the 12th Annual Virtual Health Care Conference.

What will be covered?

We cover many varied aspects of the current health care and life sciences legal environment. Here is a list of the scheduled sessions:

Regulatory Investigations in the Pharmaceutical Industry

Natasha Tardif, Jieni Ji, and Jeff Layne will discuss how companies can limit their risk of becoming subject to regulatory investigations and how they can best prepare for when such investigations do take place. 

Fraud and Abuse Enforcement in Health Care: Evolving Government Priorities and High Risk Areas in 2026

Brian Bewley, Michelle Mantine, Katie Dunn, and David Bender will examine the DOJ, HHS-OIG, CMS, and SEC enforcement priorities for 2026—including the government's deployment of AI-driven detection tools and novel applications of FCA liability—while providing practical guidance on compliance vulnerabilities across provider, manufacturer, and life sciences organizations.

Government Scrutiny of Gender Affirming Care: Risks and Considerations for Health Care Providers and Life Sciences Companies

Lesley Reynolds, Sarah Cummings Stewart, and Kristin Parker will assess recent legal, regulatory, enforcement, and litigation developments relating to gender affirming care in both the pediatric and adult contexts, including the steps taken in recent months to curtail transgender care for minors even in states where it remains legal. 

Legal Considerations for Users and Suppliers of Health-Specific AI Model Ecosystems

Wendell Bartnick, Vicki Tankle, and Sung Park will discuss how tech suppliers are offering scalable and flexible AI ecosystems targeted to health care and digital health companies, as well as sources and mitigations of regulatory and commercial risk from FDA, privacy, intellectual property, and other perspectives.

A Rise in Challenges at the NAD: A practical guide to how to keep your competitors honest in a predictable, cost-effective forum

John Feldman, Sarah Thompson Schick, and Julia Solomon Ensor will explore how the National Advertising Division (NAD) process applies to pharmaceutical and medical device companies, examine recent cases and the types of claims at issue, and highlight strategies companies have used to effectively compete on a level playing field.

PBM Litigation Trends: Where Are We and Where Are We Going

Selina Coleman, Nick Rodriguez, and Megan Ali will update pharmacies, providers, payors, pharmaceutical manufacturers, and other interested parties on recent litigation filed against PBMs by the FTC, states, pharmacies, and putative classes challenging PBMs’ practices.

Health Care Policy at an Inflection Point

Scot Hasselman and Matt Loughran will cover federal legislation and regulatory developments that have begun to shape the realm of health care law in 2026 and beyond.

Is there CLE available?

As with all good legal questions the answer to that one is . . . it depends.

The session “Fraud and Abuse Enforcement in Health Care: Evolving Government Priorities and High Risk Areas in 2026” is presumptively approved for 1.5 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Applications for CLE credit will be filed in Colorado, Delaware, Florida, Georgia, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance, but Reed Smith only provides credit for the states listed.

All other sessions are presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Applications for CLE credit will be filed in Colorado, Delaware, Florida, Georgia, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance, but Reed Smith only provides credit for the states listed.

Please allow 4-6 weeks after the program to receive a certificate of attendance.

Any further CLE Questions? You can contact Reed Smith's Learning & Development CLE Attendance Group.